- Two large-bore IVs, type & cross, restrictive transfusion: Hb <7 (<8 with cardiovascular disease).
- Glasgow-Blatchford ≤1 → can be outpatient.
- Non-variceal: IV PPI (pantoprazole 80 mg IV, then 40 mg BID) → EGD within 24 h.
- Cirrhosis / suspected varices: octreotide + ceftriaxone 1 g/day + EGD within 12 h with band ligation. Avoid overtransfusion (raises portal pressure).
- Erythromycin 250 mg IV 30–120 min before EGD clears the stomach.
- Reverse anticoagulation for life-threatening bleeding.
Pathophysiology in 60 seconds
⌄
- Upper GI = above the ligament of Treitz. Most common: peptic ulcer (H. pylori, NSAIDs, aspirin), then varices, esophagitis, Mallory-Weiss, Dieulafoy, tumor, angiodysplasia.
- Varices: portal pressure (HVPG) >10–12 mmHg → collaterals → thin-walled veins rupture. More volume = more pressure = more bleeding.
- BUN rises because blood protein is absorbed in the small bowel.
Diagnosis
⌄
| Glasgow-Blatchford components | |
|---|---|
| BUN | ↑ points |
| Hb (sex-specific) | ↓ points |
| SBP | <110 ↑ |
| HR ≥100, melena, syncope, liver disease, HF | +1–2 each |
| Score 0–1 | Very low risk → outpatient EGD |
- Melena = ~>50–100 mL of upper bleed. Bright red blood per rectum + shock can be a brisk upper bleed (check BUN, consider EGD first).
- Forrest classification at EGD: Ia spurting, Ib oozing, IIa visible vessel, IIb adherent clot → endoscopic therapy; IIc flat spot, III clean base → low risk.
Management
⌄
- IV PPI before EGD (downstages lesions).
- After endoscopic therapy of high-risk ulcer → high-dose PPI for 3 days (continuous or intermittent bolus), then PO BID to 2 weeks, then daily.
- Test for H. pylori and treat. Stop NSAIDs.
- Aspirin for secondary prevention: restart as soon as hemostasis is secured (ideally within days).
- Rebleed → repeat EGD → IR embolization → surgery.
- Octreotide 50 mcg IV bolus → 50 mcg/h × 2–5 days.
- Ceftriaxone 1 g IV daily × up to 7 days (prevents infection, rebleeding, death).
- EGD ≤12 h with band ligation.
- Lactulose to prevent encephalopathy.
- Pre-emptive TIPS within 72 h for high risk (Child C 10–13, or Child B >7 with active bleeding at EGD).
- Uncontrolled → balloon tamponade (Minnesota/Blakemore) as bridge → rescue TIPS.
- Gastric varices → cyanoacrylate/BRTO/TIPS.
- Later: non-selective β-blocker (carvedilol) + repeat banding.
| Drug | Reversal for life-threatening bleed |
|---|---|
| Warfarin | 4F-PCC + vitamin K 10 mg IV |
| Apixaban / rivaroxaban | Andexanet alfa or 4F-PCC |
| Dabigatran | Idarucizumab |
| Heparin | Protamine |
| Antiplatelet | Platelets not routinely helpful |
Pitfalls
⌄
- Overtransfusing a variceal bleeder (Hb target 7–8).
- Forgetting antibiotics in cirrhosis with GI bleed.
- Holding aspirin "forever" in a stented patient.
- Tranexamic acid — no benefit (HALT-IT), more VTE.
Board corner
⌄
| Stem | Answer |
|---|---|
| Cirrhosis + hematemesis | Octreotide + ceftriaxone + EGD ≤12 h |
| Ulcer with visible vessel | Endoscopic therapy + high-dose PPI |
| Retching then hematemesis | Mallory-Weiss |
| Hb 7.6, stable, no CAD | No transfusion |
| Aortic graft + "herald" bleed | Aortoenteric fistula → CT angio, surgery |
References
⌄
- Laine L, et al. ACG Clinical Guideline: Upper GI and Ulcer Bleeding. Am J Gastroenterol. 2021;116:899.
- Kaplan DE, et al. AASLD Practice Guidance on Risk Stratification and Management of Portal Hypertension and Varices. Hepatology. 2024;79:1180.
- de Franchis R, et al. Baveno VII. J Hepatol. 2022;76:959.
- Villanueva C, et al. Transfusion strategies for UGIB. NEJM. 2013;368:11.